In people with obesity, insulin doesn’t reduce fat release from fat tissue as well as it does in lean people — but if you account for how much fat they have, insulin works just as well.
Scientific Claim
In obese adults, the suppression of plasma FFA turnover by physiological increases in insulin is impaired compared to lean adults, but when expressed per kilogram of fat mass, insulin suppression of FFA turnover is normal.
Original Statement
“Suppression of plasma FFA turnover by physiological increments in plasma insulin was impaired in obese compared with lean subjects. However, plasma FFA turnover expressed per kilogram fat mass was normally suppressed by insulin in obese subjects.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The abstract uses 'was impaired' and 'was normally suppressed' — descriptive language appropriate for an observational study. No causal verbs are used, and the claim correctly frames the finding as a relative difference.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether increasing fat mass directly causes reduced insulin-mediated suppression of FFA turnover, independent of other metabolic changes.
Whether increasing fat mass directly causes reduced insulin-mediated suppression of FFA turnover, independent of other metabolic changes.
What This Would Prove
Whether increasing fat mass directly causes reduced insulin-mediated suppression of FFA turnover, independent of other metabolic changes.
Ideal Study Design
A double-blind, placebo-controlled crossover RCT in 40 obese adults, where fat mass is experimentally increased (via controlled overfeeding) and decreased (via 12-week calorie restriction), with FFA turnover suppression measured via insulin clamp and [1-14C]palmitate before and after each phase.
Limitation: Cannot isolate fat mass effects from changes in inflammation, liver fat, or muscle insulin sensitivity.
Prospective Cohort StudyLevel 2bWhether the degree of insulin-mediated FFA suppression per fat mass predicts future insulin resistance or type 2 diabetes.
Whether the degree of insulin-mediated FFA suppression per fat mass predicts future insulin resistance or type 2 diabetes.
What This Would Prove
Whether the degree of insulin-mediated FFA suppression per fat mass predicts future insulin resistance or type 2 diabetes.
Ideal Study Design
A 15-year cohort of 800 adults with varying fat mass, measuring insulin-mediated FFA suppression per kg fat mass at baseline and tracking incidence of T2D, adjusting for baseline insulin sensitivity and lifestyle.
Limitation: Cannot prove that altered suppression causes disease — only association.
Cross-Sectional StudyLevel 3The relationship between fat mass distribution (visceral vs. subcutaneous) and insulin-mediated FFA suppression per kg fat mass.
The relationship between fat mass distribution (visceral vs. subcutaneous) and insulin-mediated FFA suppression per kg fat mass.
What This Would Prove
The relationship between fat mass distribution (visceral vs. subcutaneous) and insulin-mediated FFA suppression per kg fat mass.
Ideal Study Design
A cross-sectional study of 300 adults with BMI 25–40, using MRI to quantify visceral and subcutaneous fat, and measuring insulin-mediated FFA suppression per kg fat mass via clamp and tracer methods.
Limitation: Cannot determine if fat distribution causes differences in insulin sensitivity or vice versa.
Evidence from Studies
Supporting (1)
Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity.
This study found that in obese people, insulin doesn’t suppress fat release as well when you look at the whole body — but when you account for how much fat they have, insulin works just as well as in lean people.